SEC Filing • PFIZER INC
PFIZER INC (PFE) files 10-Q for Q3 2025
👤 SEC
📅 Nov 4, 2025 12:03 PM (5 months ago)
🐂 Somewhat positive (70%)
AI Sentiment Analysis
Based on analyst estimates for Q3 2025, Pfizer was expected to report revenue around $16.4 billion and EPS of $0.60. The actual revenue of $16.654 billion slightly beat expectations, and the reported EPS of $0.62 also exceeded the estimate. Therefore, the sentiment is somewhat positive.